Status:
NOT_YET_RECRUITING
Diastasis Recti Abdominis and a Combined Treatment With Abdominal Exercise and Radiofrequency
Lead Sponsor:
University of Castilla-La Mancha
Conditions:
Diastasis
Diastasis Recti
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Diastasis recti abdominis is a pathology that appears in a high percentage of women during the postpartum period. However, there is little evidence about its treatment. The present protocol aims to ev...
Eligibility Criteria
Inclusion
- Women diagnosed with diastasis recti abdominis (DRA)
- Age range18-45 years old
- Women not DRA treated previously
- Women not diagnosed with umbilical hernia
Exclusion
- DRA width less than 2.5cm
- Women diagnosed with intestinal disease such as irritable bowel syndrome (IBS) or Chron disease.
- Women looking for a new pregnancy or pregnant women.
- Women who can not receive diathermy treatment (e.g tumoral process, open wound in the abdominal area or any diathermy contraindication).
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06214650
Start Date
September 1 2024
End Date
December 1 2029
Last Update
May 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.